Journal of Virology, April 2001, p. 3501-3508, Vol. 75, No. 8
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.8.3501-3508.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Center for Infectious Disease and Vaccine Research, University of Massachusetts Medical School, Worcester, Massachusetts1; Department of Virology2 and Department of Immunology,3 Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand; and Department of Virus Diseases, Walter Reed Army Institute of Research, Silver Spring, Maryland4
Received 28 August 2000/Accepted 8 January 2001
The ability of dendritic cells (DCs) to shape the adaptive immune
response to viral infection is mediated largely by their maturation and
activation state as determined by the surface expression of HLA
molecules, costimulatory molecules, and cytokine production. Dengue is
an emerging arboviral disease where the severity of illness is
influenced by the adaptive immune response to the virus. In this
report, we have demonstrated that dengue virus infects and replicates
in immature human myeloid DCs. Exposure to live dengue virus led to
maturation and activation of both the infected and surrounding,
uninfected DCs and stimulated production of tumor necrosis factor alpha
(TNF-
) and alpha interferon (IFN-
). Activation of the dengue
virus-infected DCs was blunted compared to the surrounding, uninfected
DCs, and dengue virus infection induced low-level release of
interleukin-12 p70 (IL-12 p70), a key cytokine in the development of
cell-mediated immunity (CMI). Upon the addition of IFN-
, there was
enhanced activation of dengue virus-infected DCs and enhanced dengue
virus-induced IL-12 p70 release. The data suggest a model whereby DCs
are the early, primary target of dengue virus in natural infection and
the vigor of CMI is modulated by the relative presence or absence of
IFN-
in the microenvironment surrounding the virus-infected DCs.
These findings are relevant to understanding the pathogenesis of dengue
hemorrhagic fever and the design of new vaccination and therapeutic strategies.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|